Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Nuvisan Takes Over Nestlé Skin Health’s R&D - Happi

Nuvisan Takes Over Nestlé Skin Health’s R&D

FRANCE: The Nuvisan Group, a European CRO focused on early stage drug development for the life science industry, has signed an agreement with Nestlé Skin Health/Galderma to take over parts of the R&D capacities in Sophia-Antipolis, France.

The Galderma R&D site in Sophia-Antipolis, open since 2006, is one of the world’s largest research and development centers focused on medical and cosmetic solutions for the skin. The new capabilities will strengthen Nuvisan’s core service lines in bioanalysis, clinical trial supplies and pharmaceutical analytics as well as enhance the portfolio by adding GMP-API synthesis and formulation capability for prescription drugs and cosmetics.

Nuvisan intends to start its operations in Sophia Antipolis this month.

Add us as a preferred source on Google

Get the latest Happi news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Happi Newsletters